255 related articles for article (PubMed ID: 10944891)
1. [A study on the effect of combined chemotherapy on Mycobacterium avium complex pulmonary disease].
Sato K; Ebe T
Kekkaku; 2000 Jul; 75(7):471-6. PubMed ID: 10944891
[TBL] [Abstract][Full Text] [Related]
2. The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan - including a follow-up study.
Kobashi Y; Matsushima T
Respiration; 2007; 74(4):394-400. PubMed ID: 16954651
[TBL] [Abstract][Full Text] [Related]
3. [Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment].
Kobashi Y; Oka M
Kekkaku; 2008 Dec; 83(12):779-84. PubMed ID: 19172823
[TBL] [Abstract][Full Text] [Related]
4. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
Ye JJ; Wu TS; Chiang PC; Lee MH
J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
[TBL] [Abstract][Full Text] [Related]
5. [Clinical analysis of drug interaction between rifampicin and clarithromycin which are used for treating pulmonary Mycobacterium avium complex infection].
Taki H; Ogawa K; Nakagawa T; Kashima K; Tarumi O; Saitou Y; Yamada N; Tano M; Nikai T
Kekkaku; 2007 Aug; 82(8):641-6. PubMed ID: 17874572
[TBL] [Abstract][Full Text] [Related]
6. [The clinical study on efficacy of clarithromycin, levofloxacin, and streptomycin for pulmonary Mycobacterium avium-intracellulare complex infection].
Taga S; Ogawa K; Nakagawa T; Tano M
Kekkaku; 2005 Jan; 80(1):1-7. PubMed ID: 15839056
[TBL] [Abstract][Full Text] [Related]
7. [Perspective of pulmonary MAC infection treatment].
Kurashima A
Kekkaku; 2007 Mar; 82(3):195-9. PubMed ID: 17444124
[TBL] [Abstract][Full Text] [Related]
8. [Effect of combined chemotherapy following the guidelines on treatment for Mycobacterium avium complex pulmonary disease].
Kobashi Y; Okimoto N; Matsushima T; Shigetou E; Kuraoka T; Takeyama H; Eda R; Yano S; Kobayashi K; Ohnishi T; Mori K; Ueda Y; Moritaka T; Nishimura K; Abe T
Kekkaku; 2002 Jun; 77(6):435-41. PubMed ID: 12136597
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment.
Int J Tuberc Lung Dis; 2002 Jul; 6(7):628-34. PubMed ID: 12102303
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
Miwa S; Shirai M; Toyoshima M; Shirai T; Yasuda K; Yokomura K; Yamada T; Masuda M; Inui N; Chida K; Suda T; Hayakawa H
Ann Am Thorac Soc; 2014 Jan; 11(1):23-9. PubMed ID: 24298907
[TBL] [Abstract][Full Text] [Related]
11. Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex.
Griffith DE; Brown BA; Cegielski P; Murphy DT; Wallace RJ
Clin Infect Dis; 2000 Feb; 30(2):288-92. PubMed ID: 10671330
[TBL] [Abstract][Full Text] [Related]
12. [Non-tuberculous mycobacteriosis. What has been coming out].
Kajiki A
Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655
[TBL] [Abstract][Full Text] [Related]
13. Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones.
Watanabe M; Hasegawa N; Ishizaka A; Asakura K; Izumi Y; Eguchi K; Kawamura M; Horinouchi H; Kobayashi K
Ann Thorac Surg; 2006 Jun; 81(6):2026-30. PubMed ID: 16731124
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapeutic regimens that were considered effective to cure pulmonary infection caused by Mycobacterium avium-Mycobacterium intracellulare complex].
Tsukamura M
Kekkaku; 1991 May; 66(5):375-80. PubMed ID: 1875580
[TBL] [Abstract][Full Text] [Related]
15. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
Ogawa K; Sano C
Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of non-tuberculous pulmonary mycobacteriosis].
Sakatani M; Nakajima Y
Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
[TBL] [Abstract][Full Text] [Related]
17. [Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (2) Multi-drug chemotherapy for initial cases on trial].
Tanaka E
Kekkaku; 1996 Sep; 71(9):547-9. PubMed ID: 8999140
[No Abstract] [Full Text] [Related]
18. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease.
Koh WJ; Jeong BH; Jeon K; Lee SY; Shin SJ
Am J Respir Crit Care Med; 2012 Oct; 186(8):797-802. PubMed ID: 22878282
[TBL] [Abstract][Full Text] [Related]
19. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease.
Tanaka E; Kimoto T; Tsuyuguchi K; Watanabe I; Matsumoto H; Niimi A; Suzuki K; Murayama T; Amitani R; Kuze F
Am J Respir Crit Care Med; 1999 Sep; 160(3):866-72. PubMed ID: 10471610
[TBL] [Abstract][Full Text] [Related]
20. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
